22 Tips to Transform Your Financial Life After a Divorce
Good News, Summer Travelers: Gas Prices Are Way Down
I Arm-Wrestled NFL Rookie Dee Ford to Teach Athletes About Money
Market Close: Weak Reports from Visa, Amazon Hurt Stocks
Is Celgene the Perfect Stock?
Merck has confirmed that it halted its late-stage student of vorapaxar, a potential clot-preventing drug, after an increased risk of bleeding in some patients.